{{Rsnum
|rsid=1528753
|Chromosome=11
|position=91151171
|Orientation=plus
|GMAF=0.3223
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 4.5 | 31.2 | 64.3
| HCB | 9.6 | 41.2 | 49.3
| JPT | 6.2 | 31.0 | 62.8
| YRI | 38.1 | 44.9 | 17.0
| ASW | 42.1 | 33.3 | 24.6
| CHB | 9.6 | 41.2 | 49.3
| CHD | 18.3 | 38.5 | 43.1
| GIH | 1.0 | 21.8 | 77.2
| LWK | 35.5 | 49.1 | 15.5
| MEX | 5.2 | 22.4 | 72.4
| MKK | 29.5 | 49.4 | 21.2
| TSI | 5.9 | 36.3 | 57.8
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1528753
|PubMedID=17903295
|Condition=Aging traits
|Gene=Intergenic
|Risk Allele=
|pValue=8.00E-008
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1528753
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903295; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study (Initial Sample Size: 1,345 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Aging traits.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356443
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1528753
|overall_frequency_n=87
|overall_frequency_d=124
|overall_frequency=0.701613
|n_genomes=46
|n_genomes_annotated=0
|n_haplomes=73
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}